NRx Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.15 | $0 | |||
| 08/14/2024 | Q2 2024 | -$0.75 | $0 | |||
| 05/14/2024 | Q1 2024 | -$0.74 | $0 | |||
| 04/29/2024 | Q4 2023 | -$0.05 | $8,000 | |||
| 09/29/2023 | Q3 2023 | -$0.07 | $0 | |||
| 08/14/2023 | Q2 2023 | -$0.12 | $0 | |||
| 05/15/2023 | Q1 2023 | -$0.19 | $0 | |||
| 05/01/2023 | Q4 2022 | -$0.09 | $0 | |||
| 11/14/2022 | Q3 2022 | -$0.14 | $0 | |||
| 08/15/2022 | Q2 2022 | -$0.07 | $0 | |||
| 05/16/2022 | Q1 2022 | -$0.18 | $0 | |||
| 03/31/2022 | Q4 2021 | -$0.60 | $0 | |||
| 11/15/2021 | Q3 2021 | -$0.38 | $0 | |||
| 08/16/2021 | Q2 2021 | -$0.38 | $0 | |||
| 05/20/2021 | Q1 2021 | -$0.71 | $0 | |||
| 04/01/2021 | Q4 2020 | -$16.73 | $0 | |||
| 11/16/2020 | Q3 2020 | -$0.14 | $0 | |||
| 08/14/2020 | Q2 2020 | $0.00 | $0 | |||
| 05/15/2020 | Q1 2020 | -$0.15 | $0 | |||
| 03/30/2020 | Q4 2019 | -$0.16 | $0 |
NRx Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is NRx Pharmaceuticals, Inc.'s earnings date?
NRx Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based off last year's report dates.
-
How can I listen to NRx Pharmaceuticals, Inc.'s earnings conference call?
The conference call for NRx Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read NRx Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for NRx Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does NRx Pharmaceuticals, Inc. generate each year?
NRx Pharmaceuticals, Inc. (:NRXPW) has a recorded net income of $0. NRx Pharmaceuticals, Inc. has generated $-3.98 earnings per share over the last four quarters.
-
What is NRx Pharmaceuticals, Inc.'s price-to-earnings ratio?
NRx Pharmaceuticals, Inc. (:NRXPW) has a price-to-earnings ratio of -0.68 and price/earnings-to-growth ratio is 0.16.
